Cell-Free Blood DNA Tests Less Effective Than Other CRC Screening

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Oct 30, 2024.

By Elana Gotkine HealthDay Reporter

WEDNESDAY, Oct. 30, 2024 -- Cell-free DNA blood tests (cf-bDNA) may be more costly and less effective for colorectal cancer (CRC) screening than other screening modalities, according to a study published online Oct. 29 in the Annals of Internal Medicine.

Uri Ladabaum, M.D., from the Stanford University School of Medicine in California, and colleagues estimated the clinical and economic impacts of novel CRC screening tests in a cost-effectiveness analysis using published data for average-risk persons ages 45 to 100 years.

The researchers found that compared with no screening for CRC, the relative rates for CRC incidence were 0.21, 0.29, 0.33, 0.32, 0.58, and 0.58 for colonoscopy every 10 years, annual fecal immunochemical test (FIT), and triennial next-generation multitarget stool DNA, FIT-RNA, cf-bDNA (Guardant Shield), and cf-bDNA (Freenome), respectively; the corresponding relative rates for CRC mortality were 0.19, 0.25, 0.28, 0.28, 0.44, and 0.46. Compared with no screening, the cf-bDNA test (Shield) cost $89,600 per quality-adjusted life-year gained; alternatives were more effective and less costly. In a sensitivity analysis, when novel test intervals were shortened to two or one years, incremental costs exceeded incremental benefits. Assuming equal colonoscopy follow-up, the cf-bDNA test matched FIT's impact on CRC mortality at 1.35-fold that of FIT's uptake rate. CRC deaths increased if persons who accept colonoscopy or stool tests shifted to cf-bDNA.

"The blood tests are certainly much better than nothing, but you'll worsen the population outcomes and raise health care costs if you see people switching from colonoscopies to first-generation blood tests," Ladabaum said in a statement.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-10-31 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords